Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1632, 2008-01, pp. : 27-27
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
NICE recommends nilotinib and golimumab . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. :
Access to resources
Recommend
Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. :
Golimumab grabs the limelight in psoriatic arthritis
Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. :
Golimumab, adalimumab and etanercept add up for AS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 643, 2011-01 ,pp. :
GOlimumab GOes for GOld to treat rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. :